The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.
Open accessAbstract
Recombinant adenoviruses are attractive vehicles for liver-directed gene therapy because of the high efficiency with which they transfer genes to hepatocytes in vivo. First generation recombinant adenoviruses deleted of E1 sequences also express recombinant and early and late viral genes, which lead to development of destructive cellular immune responses. Previous studies indicated that class I major histocompatibility complex (MHC)-restricted cytotoxic T lymphocytes (CTLs) play a major role in eliminating virus-infected cells. The present studies utilize mouse models to evaluate the role of T-helper cells in the primary response to adenovirus-mediated gene transfer to the liver. In vivo ablation of CD4+ cells or interferon gamma (IFN-gamma) was sufficient to prevent the elimination of adenovirus-transduced hepatocytes, despite the induction of a measurable CTL response. Mobilization of an effective TH1 response as measured by in vitro proliferation assays was associated with substantial upregulation of MHC class I expression, an effect that was prevented in IFN-gamma-deficient animals. These results suggest that elimination of virus-infected hepatocytes in a primary exposure to recombinant adenovirus requires both induction of antigen-specific CTLs as well as sensitization of the target cell by TH1-mediated activation of MHC class I expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lymphocyte responses and cytokines
Paul, W. E., & Seder, R. A. (1994) · Cell · doi:10.1016/0092-8674(94)90332-8 · Cited by 1,828
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Self-citationCD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
Matloubian, M., Concepcion, R. J., & Ahmed, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8056-8063.1994 · Cited by 1,157
Yang, Y., Li, Q., Ertl, H. C., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,032
Self-citationYang, Y., Ertl, H. C. J., & Wilson, J. M. (1994) · Immunity · doi:10.1016/1074-7613(94)90074-4 · Cited by 611
Self-citationImmune function in mice lacking the perforin gene.
Walsh, C. M., Matloubian, M., Liu, C. C., Ueda, R., Kurahara, C. G., Christensen, J. L., Huang, M. T., Young, J. D., Ahmed, R., & Clark, W. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10854 · Cited by 459
Yang, Y., Nunes, F. A., Berencsi, K., Gönczöl, E., Engelhardt, J. F., & Wilson, J. M. (1994) · Nature Genetics · doi:10.1038/ng0794-362 · Cited by 450
Self-citationMechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.
Ando, K., Moriyama, T., Guidotti, L. G., Wirth, S., Schreiber, R. D., Schlicht, H. J., Huang, S. N., & Chisari, F. V. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1541 · Cited by 449
Gene therapy: adenovirus vectors
Kozarsky, K. F., & Wilson, J. M. (1993) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(93)90126-a · Cited by 419
Self-citationLymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules
Henkart, P. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90063-9 · Cited by 386
Eichelberger, M., Allan, W., Zijlstra, M., Jaenisch, R., & Doherty, P. C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.875 · Cited by 366
Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice
Battegay, M., Moskophidis, D., Rahemtulla, A., Hengartner, H., Mak, T. W., & Zinkernagel, R. M. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4700-4704.1994 · Cited by 320
Engelhardt, J. F., Yang, Y., Stratford-Perricaudet, L. D., Allen, E. D., Kozarsky, K., Perricaudet, M., Yankaskas, J. R., & Wilson, J. M. (1993) · Nature Genetics · doi:10.1038/ng0593-27 · Cited by 294
Self-citationFellous, M., Nir, U., Wallach, D., Merlin, G., Rubinstein, M., & Revel, M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3082 · Cited by 261
IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells.
Maraskovsky, E., Chen, W. F., & Shortman, K. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1210 · Cited by 238
Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells
Hou, S., Doherty, P. C., Zijlstra, M., Jaenisch, R., & Katz, J. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.4.1319 · Cited by 234
Prolonged Transgene Expression in Cotton Rat Lung with Recombinant Adenoviruses Defective in E2a
Engelhardt, J. F., Litzky, L., & Wilson, J. M. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.10-1217 · Cited by 208
Self-citationMorris, A. G., Lin, Y.-L., & Askonas, B. A. (1982) · Nature · doi:10.1038/295150a0 · Cited by 199
Engelhardt, J. F., Simon, R. H., Yang, Y., Zepeda, M., Weber-Pendleton, S., Doranz, B., Grossman, M., & Wilson, J. M. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.6-759 · Cited by 195
Self-citationLymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.
Issekutz, T. B., Stoltz, J. M., & vd Meide, P. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.9.2989 · Cited by 168
Jennings, S. R., Bonneau, R. H., Smith, P. M., Wolcott, R. M., & Chervenak, R. (1991) · Cellular Immunology · doi:10.1016/0008-8749(91)90194-g · Cited by 125
NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A
Spergel, J. M., Hsu, W., Akira, S., Thimmappaya, B., Kishimoto, T., & Chen‐Kiang, S. (1992) · Journal of Virology · doi:10.1128/jvi.66.2.1021-1030.1992 · Cited by 93
Wille, A. H., Gessner, A., Lother, H., & Lehmann-Grube, F. (1989) · European Journal of Immunology · doi:10.1002/eji.1830190720 · Cited by 71
Hou, S., Mo, X. Y., Hyland, L., & Doherty, P. C. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1429-1434.1995 · Cited by 63
Yamasaki, T., Handa, H., Yamashita, J., Watanabe, Y., Namba, Y., & Hanaoka, M. (1984) · PubMed · Cited by 63
Leist, T. P., Köhler, M., & Zinkernagel, R. M. (1989) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1989.tb02476.x · Cited by 54
Cited by
Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 491
Jooss, K., Yang, Y., Fisher, K. J., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4212-4223.1998 · Cited by 470
“Target cell destruction is mediated, in part, by antigenspecific class I-restricted cytotoxic T lymphocytes (CTL) to both transgene product and newly expressed viral protein (39, 46, 47, 51, 52, 54).”
BackgroundSelf-citationThe Innate Immune Response to Adenovirus Vectors
Muruve, D. A. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1157 · Cited by 407
Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy
Gao, G. P., Yang, Y., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8934-8943.1996 · Cited by 370
Self-citationRaper, S. E., Yudkoff, M., Chirmule, N., Gao, G.-P., Nunes, F., Haskal, Z. J., Furth, E. E., Propert, K. J., Robinson, M. B., Magosin, S., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712719 · Cited by 354
Self-citation
Metadata
- Authors
- Yang, Y., Xiang, Z., Ertl, H. C., & Wilson, J. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-08
- Volume
- 92
- Issue
- 16
- Pages
- 7257-7261
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2166835758
- Cited by
- 260
- References
- 28
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.